ViewRay, Inc. provided revenue guidance for the full year 2022. The Company updated its 2022 guidance. The Company is again raising the bottom end of its revenue guidance from $90 million to $94 million, and reiterated the top end of the range of $104 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
11/04 | North American Morning Briefing : Stock Futures -2- | DJ |
12/03 | Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products | MT |
1st Jan change | Capi. | |
---|---|---|
-.--% | 183 | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- VRAYQ Stock
- News ViewRay, Inc.
- ViewRay, Inc. Provides Revenue Guidance for the Full Year 2022